We are boosting cell rejuvenation to treat currently incurable neurodegenerative and rare genetic diseases
Autophagy (from the Latin: ”self-eating”) is the cell’s main method for recycling damaged components and this process declines with age. There is compelling evidence that boosting autophagy leads to increased healthspan and lifespan.
We are enhancing healthspan, by building an unbiased data-driven drug discovery engine
We’re letting our proprietary data guide us in new and unexpected directions to find better ways to boost autophagy. This approach allows us to uncover brand new biology and gives us new and fundamental insights into how the cell controls this process.
Introducing Samara
Rejuvenating cells
Restoring health
Reversing disease
The Lysoseeker™ Platform
A unique approach for discovering new autophagy therapeutics.
Rare Monogenic Disease
What if we could offer real hope for serious rare genetic diseases?
Neurodegeneration
What if we could tackle the cause of Alzheimer’s and Parkinson’s Disease?
Our Pipeline
Samsara is leveraging its knowledge of new autophagy biology.
Further Pipeline Expansion
Samsara Therapeutics Receives $3.2 Million Seed Funding for Further Pipeline Expansion.
Autophagy, healthspan and lifespan
Our strategy in Samsara is to treat diseases where there is a high unmet need. But we also want to find out how our molecules work to affect healthspan and longevity.
Introducing Samsara
Over the last twenty years or so, the phenomenon of autophagy has become a hot topic in the world of biology.
© 2021 Samsara Therapeutics | Legal Information | Privacy
© 2021 Samsara Therapeutics
Legal Information | Privacy